FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for fluphenazine decanoate, a long-acting antipsychotic, from Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

ORIG AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)